Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Atrial septal defect Stories

2012-03-15 17:12:08

International multi-site randomized study led by Anthony Furlan, M.D., of University Hospitals Case Medical Center A catheter procedure that closes a hole in patients' hearts was no more effective than medical therapy in preventing recurrent strokes, according to a new study published in the March 15 issue of the New England Journal of Medicine. In the CLOSURE I trial, clinical researchers compared a catheter procedure plus medical therapy with medications alone to prevent new strokes...

2012-03-14 16:00:00

CLEVELAND, March 14, 2012 /PRNewswire/ -- A catheter procedure that closes a hole in patients' hearts is no more effective than medical therapy in preventing recurrent strokes, according to a new study published in the March 15 issue of the New England Journal of Medicine. In the CLOSURE I trial, clinical researchers compared a catheter procedure plus medical therapy with medications alone to prevent new strokes or transient ischemic attacks (TIAs) in patients between 18 and 60 years old...

2011-10-28 04:43:00

JENA, Germany, October 28, 2011 /PRNewswire/ -- Occlutech, a leading European developer of septum occluders such as PFO and ASD devices as well as other innovative, minimally invasive cardiac implants, today announced that it got a favorable ruling in patent litigation with St Jude-AGA Medical from the District Court of Milan in Italy. In the ruling, the court stated that Occlutech is not infringing the Italian part of patent EP0808138 as alleged by St Jude-AGA Medical....

2011-09-26 04:38:00

JENA, Germany, September 26, 2011 /PRNewswire/ -- Occlutech, a leading European developer of implants for treating structural heart disease today announced that its CEO, Mr Tor Peters, has obtained a favorable ruling from the district court in Duesseldorf in patent litigation initiated personally against him by St Jude AGA Medical. On the 10th of May 2011, Occlutech GmbH won an over 5 years long patent lawsuit initiated by St Jude-AGA Medical at the German Supreme Court...

2011-08-24 03:07:00

JENA, Germany, August 24, 2011 /PRNewswire/ -- Occlutech, a leading European developer of medical implants treating structural heart disease such as PFO, ASD and LAA today announced the closing of a 15 million Euro investment into Occlutech. The investment was lead by Hong Kong based Interlink Investments Ltd. and subscribed by investors as well as Occlutech distribution partners from Japan, Switzerland, Ireland, Austria and Turkey. Tor Peters, CEO, said in a statement;...

2011-05-17 08:10:00

WELLESLEY HILLS, Mass., May 17, 2011 /PRNewswire/ -- NMT Medical, Inc. adds intellectual property, which has been assigned to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP to be liquidated for the benefit of NMT Medical creditors, to its sealed bid sale of June 10, 2011. The intellectual property is: Nitinol and Other Novel Implants for Septal Defect Repair Radiofrequency Technology for Closure of Patent Foramen Ovale (PFO) Adhesive Technology for...

2011-05-12 10:37:00

JENA, Germany, May 12, 2011 /PRNewswire/ -- Occlutech GmbH, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced that it has received a favourable court ruling from the German Supreme Court, (BGH), in Karlsruhe, Gerrmany in patent litigation initiated by AGA Medical Inc., now part of St. Jude Medical Inc. In the ruling by the BGH, the court does not see any basis for AGA / St. Jude's claim that the Occlutech ASD...

2011-05-01 00:09:07

Four Iraqi Children Transported To Jordan To Receive Life Saving Heart Surgeries Amman, Jordan (PRWEB) April 29, 2011 Flowing into the Dead Sea, the River Jordan is undoubtedly a major source of water for Jordan and neighboring Israel, Syria and Lebanon, but it is most notably a historic site for Christ"Ëœs baptismal by the Prophet John, signifying the beginning of Jesus Christ"Ëœs ministry and the teachings of salvation and forgiveness, death and resurrection. Easter...

2011-03-31 14:01:14

Roughly 15% of children suffer from migraines, and approximately one-third of these affected children have migraines with aura, a collection of symptoms that can include weakness, blind spots, and even hallucinations. Although the causes of migraines are unclear, a new study soon to be published in The Journal of Pediatrics suggests a connection between migraine headaches in children and a heart defect called patent foramen ovale, which affects 25% of people in the U.S. Dr. Rachel McCandless...

2011-03-04 10:33:00

JENA, Germany, March 4, 2011 /PRNewswire/ -- Occlutech GmbH, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced that it has received a favourable court ruling from Stockholm, Sweden in the on-going patent litigation with AGA Medical -St Jude Medical. In the ruling by Stockholms tingsratt , the district court of Stockholm, the court does not see any basis for AGA-St Jude's claim that the Occlutech ASD and PFO...


Latest Atrial septal defect Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »